Braslyn Ltd. Insider Trading $MYG Mirati Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Braslyn Ltd..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Braslyn Ltd.. Braslyn Ltd. is 10% Owner in INSEEGO CORP. ($INSG) and 10% Owner in Mirati Therapeutics, Inc. ($MYG).
Braslyn Ltd. in Mirati Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Braslyn Ltd.: 10% Owner
Holdings: 3,134,859 shares
Latest Transaction: Mar 10 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Braslyn Ltd. in Mirati Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10 2021 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Option Exercise | M | 0.00 | 410 | 0 | 3,578,040 | |
| Mar 10 2021 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Option Exercise | M | 0.00 | 11,971 | 12 | 3,578,450 | |
| Mar 10 2021 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 195.90 | 1 | 196 | 3,135,966 | 3.1 M to 3.1 M (0.00 %) |
| Mar 10 2021 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | M | 0.00 | 410 | 0 | 3,135,967 | 3.1 M to 3.1 M (+0.01 %) |
| Mar 10 2021 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 198.00 | 200 | 39,600 | 3,135,557 | 3.1 M to 3.1 M (-0.01 %) |
| Mar 10 2021 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 196.12 | 20 | 3,922 | 3,135,757 | 3.1 M to 3.1 M (0.00 %) |
| Mar 10 2021 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 195.52 | 189 | 36,953 | 3,135,777 | 3.1 M to 3.1 M (-0.01 %) |
| Mar 10 2021 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 191.00 | 1 | 191 | 3,135,966 | 3.1 M to 3.1 M (0.00 %) |
| Mar 10 2021 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | M | 0.00 | 11,971 | 12 | 3,135,967 | 3.1 M to 3.1 M (+0.38 %) |
| Mar 10 2021 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 199.08 | 2,237 | 445,342 | 3,123,996 | 3.1 M to 3.1 M (-0.07 %) |
| Mar 10 2021 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 197.81 | 3,993 | 789,855 | 3,126,233 | 3.1 M to 3.1 M (-0.13 %) |
| Mar 10 2021 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 197.30 | 4,633 | 914,091 | 3,130,226 | 3.1 M to 3.1 M (-0.15 %) |
| Mar 10 2021 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 195.82 | 1,107 | 216,773 | 3,134,859 | 3.1 M to 3.1 M (-0.04 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Option Exercise | M | 0.00 | 104,565 | 105 | 3,590,421 | |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Option Exercise | M | 0.00 | 295,438 | 295 | 3,694,986 | |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Option Exercise | M | 0.00 | 104,565 | 105 | 3,590,421 | |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Payment of Exercise | F | 202.25 | 1 | 202 | 3,135,966 | 3.1 M to 3.1 M (0.00 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Option Exercise | M | 0.00 | 295,438 | 295 | 3,694,986 | |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | M | 0.00 | 104,565 | 105 | 3,135,967 | 3 M to 3.1 M (+3.45 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Payment of Exercise | F | 202.25 | 1 | 202 | 3,135,966 | 3.1 M to 3.1 M (0.00 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 220.02 | 818 | 179,980 | 3,031,402 | 3 M to 3 M (-0.03 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | M | 0.00 | 104,565 | 105 | 3,135,967 | 3 M to 3.1 M (+3.45 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 218.85 | 663 | 145,098 | 3,032,220 | 3 M to 3 M (-0.02 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 220.02 | 818 | 179,980 | 3,031,402 | 3 M to 3 M (-0.03 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 218.04 | 5,912 | 1,289,025 | 3,032,883 | 3 M to 3 M (-0.19 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 218.85 | 663 | 145,098 | 3,032,220 | 3 M to 3 M (-0.02 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 217.15 | 6,775 | 1,471,157 | 3,038,795 | 3 M to 3 M (-0.22 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 218.04 | 5,912 | 1,289,025 | 3,032,883 | 3 M to 3 M (-0.19 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 216.06 | 11,656 | 2,518,338 | 3,045,570 | 3.1 M to 3 M (-0.38 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 217.15 | 6,775 | 1,471,157 | 3,038,795 | 3 M to 3 M (-0.22 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 215.08 | 27,992 | 6,020,396 | 3,057,226 | 3.1 M to 3.1 M (-0.91 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 216.06 | 11,656 | 2,518,338 | 3,045,570 | 3.1 M to 3 M (-0.38 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 214.31 | 2,344 | 502,335 | 3,085,218 | 3.1 M to 3.1 M (-0.08 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 215.08 | 27,992 | 6,020,396 | 3,057,226 | 3.1 M to 3.1 M (-0.91 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 212.66 | 3,108 | 660,947 | 3,087,562 | 3.1 M to 3.1 M (-0.10 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 214.31 | 2,344 | 502,335 | 3,085,218 | 3.1 M to 3.1 M (-0.08 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 211.50 | 14,408 | 3,047,340 | 3,090,670 | 3.1 M to 3.1 M (-0.46 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 212.66 | 3,108 | 660,947 | 3,087,562 | 3.1 M to 3.1 M (-0.10 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 210.58 | 10,599 | 2,231,945 | 3,105,078 | 3.1 M to 3.1 M (-0.34 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 211.50 | 14,408 | 3,047,340 | 3,090,670 | 3.1 M to 3.1 M (-0.46 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 209.66 | 15,091 | 3,163,970 | 3,115,677 | 3.1 M to 3.1 M (-0.48 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 210.58 | 10,599 | 2,231,945 | 3,105,078 | 3.1 M to 3.1 M (-0.34 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 208.78 | 1,674 | 349,498 | 3,130,768 | 3.1 M to 3.1 M (-0.05 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 209.66 | 15,091 | 3,163,970 | 3,115,677 | 3.1 M to 3.1 M (-0.48 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 207.96 | 1,086 | 225,849 | 3,132,442 | 3.1 M to 3.1 M (-0.03 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 208.78 | 1,674 | 349,498 | 3,130,768 | 3.1 M to 3.1 M (-0.05 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 206.50 | 1,088 | 224,671 | 3,133,528 | 3.1 M to 3.1 M (-0.03 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 207.96 | 1,086 | 225,849 | 3,132,442 | 3.1 M to 3.1 M (-0.03 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 205.65 | 800 | 164,516 | 3,134,616 | 3.1 M to 3.1 M (-0.03 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 206.50 | 1,088 | 224,671 | 3,133,528 | 3.1 M to 3.1 M (-0.03 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 203.32 | 550 | 111,828 | 3,135,416 | 3.1 M to 3.1 M (-0.02 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 205.65 | 800 | 164,516 | 3,134,616 | 3.1 M to 3.1 M (-0.03 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Payment of Exercise | F | 209.16 | 2 | 418 | 3,135,966 | 3.1 M to 3.1 M (0.00 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 203.32 | 550 | 111,828 | 3,135,416 | 3.1 M to 3.1 M (-0.02 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | M | 0.00 | 295,438 | 295 | 3,135,968 | 2.8 M to 3.1 M (+10.40 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Payment of Exercise | F | 209.16 | 2 | 418 | 3,135,966 | 3.1 M to 3.1 M (0.00 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 211.06 | 500 | 105,532 | 2,840,530 | 2.8 M to 2.8 M (-0.02 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | M | 0.00 | 295,438 | 295 | 3,135,968 | 2.8 M to 3.1 M (+10.40 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 210.31 | 23,283 | 4,896,648 | 2,841,030 | 2.9 M to 2.8 M (-0.81 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 211.06 | 500 | 105,532 | 2,840,530 | 2.8 M to 2.8 M (-0.02 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 209.47 | 37,428 | 7,840,043 | 2,864,313 | 2.9 M to 2.9 M (-1.29 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 210.31 | 23,283 | 4,896,648 | 2,841,030 | 2.9 M to 2.8 M (-0.81 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 208.40 | 25,036 | 5,217,502 | 2,901,741 | 2.9 M to 2.9 M (-0.86 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 209.47 | 37,428 | 7,840,043 | 2,864,313 | 2.9 M to 2.9 M (-1.29 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 207.35 | 38,525 | 7,988,159 | 2,926,777 | 3 M to 2.9 M (-1.30 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 208.40 | 25,036 | 5,217,502 | 2,901,741 | 2.9 M to 2.9 M (-0.86 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 206.50 | 41,266 | 8,521,429 | 2,965,302 | 3 M to 3 M (-1.37 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 207.35 | 38,525 | 7,988,159 | 2,926,777 | 3 M to 2.9 M (-1.30 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 205.49 | 45,896 | 9,431,169 | 3,006,568 | 3.1 M to 3 M (-1.50 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 206.50 | 41,266 | 8,521,429 | 2,965,302 | 3 M to 3 M (-1.37 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 204.57 | 38,543 | 7,884,742 | 3,052,464 | 3.1 M to 3.1 M (-1.25 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 205.49 | 45,896 | 9,431,169 | 3,006,568 | 3.1 M to 3 M (-1.50 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 203.35 | 44,959 | 9,142,323 | 3,091,007 | 3.1 M to 3.1 M (-1.43 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 204.57 | 38,543 | 7,884,742 | 3,052,464 | 3.1 M to 3.1 M (-1.25 %) |
| Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 203.35 | 44,959 | 9,142,323 | 3,091,007 | 3.1 M to 3.1 M (-1.43 %) |
| Jun 16 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Option Exercise | M | 0.00 | 600,006 | 600 | 3,990,420 | |
| Jun 16 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Payment of Exercise | F | 72.80 | 6 | 437 | 3,135,966 | 3.1 M to 3.1 M (0.00 %) |
| Jun 16 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | M | 0.00 | 600,006 | 600 | 3,135,972 | 2.5 M to 3.1 M (+23.66 %) |
| Jun 16 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 69.00 | 600,000 | 41,400,000 | 2,535,966 | 3.1 M to 2.5 M (-19.13 %) |
| Mar 05 2019 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Option Exercise | M | 0.00 | 275,004 | 275 | 4,590,426 | |
| Mar 05 2019 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Payment of Exercise | F | 72.80 | 4 | 291 | 3,135,966 | 3.1 M to 3.1 M (0.00 %) |
| Mar 05 2019 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | M | 0.00 | 275,004 | 275 | 3,135,970 | 2.9 M to 3.1 M (+9.61 %) |
| Mar 05 2019 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 69.00 | 275,000 | 18,975,000 | 2,860,966 | 3.1 M to 2.9 M (-8.77 %) |
| Jan 30 2017 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 5.45 | 28,839 | 157,173 | 2,880,702 | 2.9 M to 2.9 M (+1.01 %) |
| Jan 30 2017 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 5.44 | 19,330 | 105,155 | 2,851,863 | 2.8 M to 2.9 M (+0.68 %) |
| Jan 25 2017 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 5.42 | 30,600 | 165,852 | 2,832,533 | 2.8 M to 2.8 M (+1.09 %) |
| Jan 25 2017 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 5.32 | 27,682 | 147,268 | 2,801,933 | 2.8 M to 2.8 M (+1.00 %) |
| Jan 25 2017 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 5.27 | 19,251 | 101,453 | 2,774,251 | 2.8 M to 2.8 M (+0.70 %) |
| Jan 20 2017 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 5.42 | 23,873 | 129,392 | 2,755,000 | 2.7 M to 2.8 M (+0.87 %) |
| Jan 20 2017 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 5.48 | 21,085 | 115,546 | 2,731,127 | 2.7 M to 2.7 M (+0.78 %) |
| Jan 20 2017 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 5.50 | 16,200 | 89,100 | 2,710,042 | 2.7 M to 2.7 M (+0.60 %) |
| Jan 17 2017 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 5.50 | 17,800 | 97,900 | 2,693,842 | 2.7 M to 2.7 M (+0.67 %) |
| Jan 17 2017 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 5.49 | 52,311 | 287,187 | 2,676,042 | 2.6 M to 2.7 M (+1.99 %) |
| Jan 17 2017 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 5.50 | 49,776 | 273,768 | 2,623,731 | 2.6 M to 2.6 M (+1.93 %) |
| Jan 10 2017 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Option Exercise | P | 0.00 | 4,865,430 | 4,865 | 4,865,430 | |
| Jan 10 2017 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 5.60 | 581,870 | 3,258,472 | 2,573,955 | 2 M to 2.6 M (+29.21 %) |
| Jun 08 2016 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 9.49 | 161,751 | 1,535,049 | 1,992,085 | 1.8 M to 2 M (+8.84 %) |
| Jun 08 2016 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 10.31 | 215,151 | 2,217,368 | 1,830,334 | 1.6 M to 1.8 M (+13.32 %) |
| May 09 2016 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 17.15 | 4,500 | 77,175 | 1,615,183 | 1.6 M to 1.6 M (+0.28 %) |
| May 09 2016 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 18.29 | 61,282 | 1,120,731 | 1,610,683 | 1.5 M to 1.6 M (+3.96 %) |
| Mar 31 2016 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 19.09 | 3,400 | 64,906 | 1,549,401 | 1.5 M to 1.5 M (+0.22 %) |
| Mar 28 2016 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 19.48 | 300 | 5,844 | 1,546,001 | 1.5 M to 1.5 M (+0.02 %) |
| Mar 28 2016 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 19.36 | 20,548 | 397,809 | 1,545,701 | 1.5 M to 1.5 M (+1.35 %) |
| Mar 22 2016 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 19.34 | 1,166 | 22,550 | 1,525,153 | 1.5 M to 1.5 M (+0.08 %) |
| Mar 17 2016 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | J | 0.00 | 375,298 | 0 | 1,523,987 | 1.1 M to 1.5 M (+32.67 %) |
| Jan 15 2016 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | J | 0.00 | 626,189 | 0 | 1,148,689 | 522.5 K to 1.1 M (+119.84 %) |
Page: 1